REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2011

Jun 22, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2011-06-20

Reporting Person: VAGELOS P ROY (Director, Chairman of the Board)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-01-12	Common Stock	G	401	—	Disposed	110111	Direct
2011-01-12	Common Stock	G	401	—	Disposed	109710	Direct
2011-01-12	Common Stock	G	401	—	Disposed	109309	Direct
2011-06-20	Common Stock	J	30778	—	Acquired	140087	Direct
2011-04-04	Common Stock	G	4954	—	Disposed	178854	Indirect
2011-06-20	Common Stock	J	30778	—	Disposed	94222	Indirect
2011-01-12	Common Stock	G	1203	—	Acquired	1203	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2271	Indirect
Common Stock	235000	Indirect

Footnotes

F1: On June 20, 2011, a GRAT of which the reporting person is a director distributed to the reporting person 30,778 shares of REGN common stock in accordance with the terms of the GRAT and a plan intended to comply with Rule 10b5-1(c).

F2: Gift of Common Stock to charitable organization.